We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Increased Dietary Salt Causes Autoimmune Diseases by Stimulating Formation of Proinflammatory TH17 Cells

By LabMedica International staff writers
Posted on 19 Mar 2013
Three recent papers linked elevated dietary salt to the development of autoimmune diseases such as multiple sclerosis and type I diabetes by demonstrating the relationship between salt levels and the generation of T helper 17 (TH17) cells.

TH17 cells (interleukin-17 (IL-17)-producing helper T cells) are highly pro-inflammatory cells that are critical for clearing extracellular pathogens and for inducing multiple autoimmune diseases. More...
To study the effect of salt concentration on TH17 cell metabolism investigators at Harvard Medical School (Boston, MA, USA) and Yale School of Medicine (New Haven, CT, USA) worked with cell cultures and with mouse populations where it was easy to adjust the level of dietary salt.

Details of the research and results were published in three papers that appeared in the March 6, 2013, online edition of the journal Nature. Among other factors, the investigators identified the protein serum glucocorticoid kinase 1 (SGK1), which is known to regulate salt levels in other types of cells, as a TH17-signal. The researchers found that mouse cells cultured in high-salt conditions had higher SGK1 expression and produced more TH17 cells than those grown in normal conditions. A modest increase in salt concentration induced SGK1 expression, promoted interleukin-23R expression, and enhanced TH17 cell differentiation in vitro and in vivo, accelerating the development of autoimmunity.

High-salt conditions activated the p38/MAPK pathway involving nuclear factor of activated T cells 5 (NFAT5; also called TONEBP) and SGK1 during cytokine-induced TH17 polarization. Gene silencing or chemical inhibition of p38/MAPK, NFAT5, or SGK1 abolished the high-salt-induced TH17 cell development. TH17 cells generated under high-salt conditions displayed a highly pathogenic and stable phenotype characterized by the upregulation of the proinflammatory cytokines.

"Humans were genetically selected for conditions in sub-Saharan Africa, where there was no salt," said senior author Dr. David Hafler, professor of neurology and immunobiology at Yale School of Medicine. "Today, Western diets all have high salt content and that has led to increase in hypertension and perhaps autoimmune disease as well. These are not diseases of bad genes alone or diseases caused by the environment, but diseases of a bad interaction between genes and the environment."

"Test-tube cell biology is performed based on the salt levels found in blood and not in the tissues where immune cells ultimately travel to fight infections," said Dr. Hafler. "That may have been a reason salt's role in autoimmunity has gone undetected. We may have been using the wrong concentrations of salt in our experiments for the past half-century. Nature did not want immune cells to become turned on in the pipeline, so perhaps blood salt levels are inhibitory."

Related Links:

Harvard Medical School
Yale School of Medicine



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.